Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 8/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.73 |
| ▸ | MAOA | P21397 | 4/20 | 0.73 |
| ▸ | MIF | P14174 | 2/20 | 0.73 |
| ▸ | HPGD | P15428 | 2/20 | 0.73 |
| ▸ | CA12 | O43570 | 2/20 | 0.73 |
| ▸ | CA9 | Q16790 | 2/20 | 0.73 |
| ▸ | TSHR | P16473 | 2/20 | 0.73 |
| ▸ | CA1 | P00915 | 1/20 | 0.73 |
| ▸ | CA3 | P07451 | 1/20 | 0.73 |
| ▸ | CA4 | P22748 | 1/20 | 0.73 |
| ▸ | CA6 | P23280 | 1/20 | 0.73 |
| ▸ | CA5A | P35218 | 1/20 | 0.73 |
| ▸ | CA7 | P43166 | 1/20 | 0.73 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.73 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.73 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.73 |
| ▸ | RAB9A | P51151 | 4/20 | 0.68 |
| ▸ | NPC1 | O15118 | 3/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5562065 | 0.95 | MAOB (0.68) | MAOBALDH1A1MAOAMIFHPGD | |
| SCHEMBL5996884 | 0.94 | MAOB (0.66) | MAOBALDH1A1MAOAMIFHPGD | |
| Coumarin SCHEMBL194933 | 0.91 | ALDH1A1 (0.67) | MAOBALDH1A1MAOAMIFHPGD | |
| SCHEMBL29539474 | 0.90 | MAOB (0.77) | MAOBALDH1A1MAOAHPGDCA12 | |
| SCHEMBL279860 | 0.90 | MAOB (0.77) | MAOBALDH1A1MAOAHPGDCA12 | |
| SCHEMBL6881825 | 0.89 | MAOB (0.72) | MAOBALDH1A1MAOAMIFHPGD | |
| SCHEMBL11097358 | 0.88 | MAOB (0.60) | MAOBALDH1A1MAOAMIFHPGD | |
| SCHEMBL28014855 | 0.88 | ALDH1A1 (0.67) | MAOBALDH1A1MAOAMIFHPGD | |
| SCHEMBL6832346 | 0.86 | MAOB (0.76) | MAOBALDH1A1MAOAMIFHPGD | |
| SCHEMBL18188888 | 0.86 | MAOB (0.62) | MAOBALDH1A1MAOAMIFHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 681 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11382868-B2 | Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same | ICURE PHARMACEUTICAL INC. (KR) | 2022-07-12 | — | — | US | claimed |
| CN-107652222-B | Oxime ester photoinitiators | 巴斯夫欧洲公司 | 2021-09-10 | — | — | CN | claimed |
| CN-106008434-B | A kind of synthetic method of 3- benzoyls coumarin kind compound | 青岛农业大学 | 2018-06-26 | — | — | CN | claimed |
| US-9834740-B2 | Photoactivators | THE PROCTER & GAMBLE COMPANY (US) | 2017-12-05 | — | — | US | claimed |
| EP-3097168-A1 | SYSTEMS AND METHODS FOR TREATING A SURFACE | The Procter & Gamble Company (US) | 2016-11-30 | — | — | EP | claimed |
| EP-3097176-A1 | PHOTOACTIVATORS | The Procter & Gamble Company (US) | 2016-11-30 | — | — | EP | claimed |
| EP-3097169-A1 | CONSUMER PRODUCT COMPOSITIONS | The Procter & Gamble Company (US) | 2016-11-30 | — | — | EP | claimed |
| CN-106008434-A | Synthetic method for 3-benzoyl coumarin compound | 青岛农业大学 | 2016-10-12 | — | — | CN | claimed |
| CN-105934510-A | Photoactivators | 宝洁公司 | 2016-09-07 | — | — | CN | claimed |
| US-20150210963-A1 | Systems and Methods for Treating a Surface | THE PROCTER & GAMBLE COMPANY | 2015-07-30 | — | — | US | claimed |
| US-20150210960-A1 | Photoactivators | THE PROCTER & GAMBLE COMPANY | 2015-07-30 | — | — | US | claimed |
| US-20150210964-A1 | Consumer Product Compositions | THE PROCTER & GAMBLE COMPANY | 2015-07-30 | — | — | US | claimed |
| WO-2015112675-A1 | PHOTOACTIVATORS | THE PROCTER & GAMBLE COMPANY (US) | 2015-07-30 | — | — | WO | claimed |
| WO-2015112667-A1 | SYSTEMS AND METHODS FOR TREATING A SURFACE | THE PROCTER & GAMBLE COMPANY (US) | 2015-07-30 | — | — | WO | claimed |
| EP-0298030-B1 | PROCESS FOR FORMING IMAGES | CIBA-GEIGY AG (CH) | 1992-10-28 | — | — | EP | claimed |
| US-5153236-A | Comprising an N-aryl-alpha-amino acid and a photosensitizer such as a thixoanthone, isoalloxazine or coumarine; high sensitivity to UV and visible light; storage stability; photoresists; relief images | HITACHI CHEMICAL CO., LTD. (JP) | 1992-10-06 | — | — | US | claimed |
| US-4978604-A | Process for forming images | CIBA-GEIGY CORPORATION (US) | 1990-12-18 | — | — | US | claimed |
| EP-0298030-A2 | Process for forming images | CIBA-GEIGY AG (CH) | 1989-01-04 | — | — | EP | claimed |
| EP-0022188-B1 | CO-INITIATOR COMPOSITIONS FOR PHOTOPOLYMERIZATION CONTAINING 3-ACYL-SUBSTITUTED COUMARINS, PHOTOPOLYMERIZABLE COMPOSITION AND PHOTOGRAPHIC ELEMENT | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1984-10-03 | — | — | EP | claimed |
| US-4147552-A | Light-sensitive compositions with 3-substituted coumarin compounds as spectral sensitizers | EASTMAN KODAK COMPANY (US) | 1979-04-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150210960-A1 | Photoactivators | NQO1, TYR, CYP1A1 | MAOB 416/4885ALDH1A1 78/4885MAOA 147/4885 |
| US-20150210963-A1 | Systems and Methods for Treating a Surface | HMBS, PPOX, TTPA | MAOB 62/4885ALDH1A1 1283/4885MAOA 29/4885 |
| US-20150210964-A1 | Consumer Product Compositions | NQO1, TYR, ETFA | MAOB 13/4885ALDH1A1 27/4885MAOA 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.